BIIB
Biogen is a global biotechnology company focused on discovering, developing, and delivering innovative medicines for serious neurological and rare diseases such as multiple sclerosis, Alzheimer's disease, ALS, spinal muscular atrophy, and lupus. Leveraging deep expertise in human biology and multiple therapeutic modalities, Biogen advances first‑in‑class treatments through extensive R&D, clinical trials, and early‑access programs, while emphasizing health equity, sustainability, and patient advocacy across its worldwide operations.